Events

Press Releases

Events

Raven biotechnologies, inc. presented at these events:

May 30-June 3, 2008
American Society of Clinical Oncology, Chicago, Illinois
Poster available to download (see below)

April 13-15, 2008
American Association for Cancer Research, San Diego, California
Posters available to download (see below)

February 13, 2008
George Schreiner, MD, PhD, Chief Executive Officer
BIO CEO & Investor Conference, New York, New York
“Creating the Next Major Therapeutic Antibody Company”

December 6, 2007
Jennie Mather, PhD, Founder, President and Chief Scientific Officer
Antibody Engineering Conference, San Diego, California
“MAbs to Cancer Stem Cell Lines Have Anti-tumor Activity”

December 5, 2007
George Schreiner, MD, PhD, Chief Executive Officer
National Institutes of Health (NIH) Workshop, Bethesda, Maryland
“Immunological Implications of Radiation Conditioning”

October 24, 2007
Kathleen King, Scientist
American Association of Cancer Research (AACR)
International Conference on Molecular Targets and Cancer Therapeutics, San Francisco, California
“Antibodies Generated by Conditioned Cell Immunization Technology Bind to Beta5 Integrin and Synergize with Chemotherapy and Radiation to Inhibit the Growth of Human Tumor Cells”

June 25, 2007
Jennie Mather, PhD, Founder, President and Chief Scientific Officer
INFORMA: 6th International Congress on Recombinant Antibodies
Novel Therapeutic Applications of Antibodies section Berlin, Germany
“Simultaneous Antibody and Target Discovery”

June 18, 2007
Jennie Mather, PhD, Founder, President and Chief Scientific Officer
24th International Conference on Advances in the Application of Monoclonal
Antibodies in Clinical Oncology Limassol, Cyprus
“RAV12: An Antibody to a Novel Glycotope Present on Adenocarcinomas”